References
- Eggermont AM, Schraffordt KH, Lienard D, Kroon BB, van Geel AN, Hoekstra HJ, Lejeune FJ. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial. J Clin Oncol 1996; 14: 2653–2665
- Lienard D, Eggermont AM, Schraffordt KH, Kroon BB, Rosenkaimer F, Autier P, Lejeune FJ. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res 1994; 4: S21–26
- Creech O, Jr, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958; 148: 616–632
- Stehlin JS, Jr, Clark RL, Jr, Dewey WC. Continuous monitoring of leakage during regional perfusion. Arch Surg 1961; 83: 943–949
- Lejeune FJ, Lienard D, Ewalenko P. Hyperthermic isolation perfusion of the limbs with cytostatics after surgical excision of sarcomas. World J Surg 1988; 12: 345–348
- Schraffordt KH, Oldhoff J, Oosterhuis JW, Beekhuis H. Isolated regional perfusion in malignant melanoma of the extremities. World J Surg 1987; 11: 527–533
- Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR. Systemic leakage during isolated limb perfusion for melanoma. Br J Surg 1993; 80: 1124–1126
- Casara D, Rubello D, Pilati P, Scalerta R, Foletto M, Rossi CR. Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mTc-HSA. Nucl Med Commun 2004; 25: 61–66
- Sandrock D, Horst F, Gatzemeier W, Ghorbani M, Rauschecker H, Munz DL, Emrich D. Leakage measurement during selective limb perfusion using a gamma probe. Eur J Nucl Med 1996; 23: 534–538
- Daryanani D, Komdeur R, Ter VJ, Nijhuis PH, Piers DA, Hoekstra HJ. Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol 2001; 8: 566–572
- ICRP Publication 60. 1990 Recommendations of the International Commission on Radiological Protection. 60. Ann ICRP 1990; 21: 1–3
- Wilson OJ, Young BF, Richardson CK. Cosmic radiation doses received by Australian commercial flight crews and the implications of ICRP 60. Health Phys 1994; 66: 493–502